paclitaxel has been researched along with Tongue Neoplasms in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (44.44) | 29.6817 |
| 2010's | 11 (40.74) | 24.3611 |
| 2020's | 4 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Hussein, HA; Khaphi, FL | 1 |
| Chiang, B; Kamiya, K; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Sashikawa, M | 1 |
| Baste, N; Even, C; Herrera Gómez, RG; Iacob, M; Mayache, L; Saleh, K | 1 |
| Bellanger, C; Classe, M; Even, C; Garcia, G; Saleh, K | 1 |
| Fan, HN; Jiang, QK; Liu, YD; Lu, HL; Qian, Y; Wang, Y; Yang, LY; Zhu, XJ | 1 |
| Gebhardt, BJ; Kirwan, J; McAfee, WJ; Mendenhall, CM; Mendenhall, WM; Morris, CG | 1 |
| Ishitoya, S; Onishi, H; Takeuchi, E; Terashima, T; Uemura, Y; Ushida, H | 1 |
| Chen, L; Chen, Y; Cheng, B; Tang, Q; Xie, M; Zhao, J; Zhou, X | 1 |
| Chen, H; Dai, D; Tang, J; Tang, Y | 1 |
| Bogardus, C; Canfield, V; Hancock, SB; Kaneaster, SK; Kojouri, K; Krempl, GA; Medina, JE | 1 |
| Hirota, M; Husain, SR; Kioi, M; Nakashima, H; Puri, RK; Shimamura, T; Tohnai, I | 1 |
| Cano, ER; Carrau, RL; Caylakli, F; Ferris, RL; Gooding, WE; Johnson, JT; Lai, SY; Myers, EN; Simenthal, AA; Snyderman, CH | 1 |
| Blair, EA; Haraf, DJ; Pederson, AW; Salama, JK; Stenson, KM; Vokes, EE; Witt, ME | 1 |
| Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
| Auzenne, E; Galer, CE; Ghosh, SC; Hah, JH; Hamir, AN; Klostergaard, J; Myers, JN; Sano, D | 1 |
| Blumenschein, G; Boatright, DH; Brandon Gunn, G; El-Naggar, AK; Kies, MS; Lewin, JS; Li, G; Steinhaus, GD; Sturgis, EM | 1 |
| Koroleva, IA; Mochalova, AS | 1 |
| Cox, J; Fritzsche, A; Gosnell, D; Graham, R; Ledwitch, K; Manning, T; Ogburn, R | 1 |
| He, ZM; Qu, XR; Shen, ZH | 1 |
| Bonaccorsi, A; Calò, S; Cantù, G; Costa, L; Crippa, F; Damascelli, B; Di Tolla, G; Frigerio, LF; Garbagnati, F; Gladin, CR; Lanocita, R; Marchianò, A; Mariani, L; Mattavelli, F; Oldini, C; Palazzi, M; Patelli, GL; Spreafico, C; Tichà, V | 1 |
| Bekele, BN; Bucana, CD; Doan, DD; Fidler, IJ; Greenberg, JS; Holsinger, FC; Jasser, SA; Myers, JN; Schiff, BA; Swan, EA; Younes, MN | 1 |
| Beri, R; Desai, SR; Pacini, MJ; Rosen, FR | 1 |
| Ghaheri, BA; Grecula, JC; Malone, JP; Rhoades, CA; Schuller, DE; Stephens, JA | 1 |
| Byers, RM; Glisson, BS; Kies, MS; Moore, BA; Shin, DM; Sturgis, EM | 1 |
| Burkey, B; Cmelak, AJ; Douglas, S; Murphy, BA; Netterville, J; Shyr, Y | 1 |
| Chen, A; Davis, L; Johnstone, PA; Lawson, JD; Otto, K; Shin, DM | 1 |
| Chang, HR; Chu, SC; Hsieh, YS; Yang, SF; Yang, WE | 1 |
1 review(s) available for paclitaxel and Tongue Neoplasms
| Article | Year |
|---|---|
Taxol: efficacy against oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Survival; Clinical Trials as Topic; Disease Models, Animal; Drug Therapy, Combination; Humans; Mouth Neoplasms; Paclitaxel; Platinum Compounds; Survival Rate; Tongue Neoplasms | 2013 |
3 trial(s) available for paclitaxel and Tongue Neoplasms
| Article | Year |
|---|---|
Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease-Free Survival; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Nervous System Diseases; Paclitaxel; Radiotherapy, Adjuvant; Survival Rate; Tongue Neoplasms | 2008 |
Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Female; Follow-Up Studies; Glossectomy; Humans; Ifosfamide; Induction Chemotherapy; Male; Middle Aged; Neck Dissection; Neoplasms, Squamous Cell; Paclitaxel; Prognosis; Survival Analysis; Tongue Neoplasms; Treatment Outcome; Young Adult | 2012 |
Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Laryngeal Neoplasms; Male; Middle Aged; Paclitaxel; Survival Rate; Tongue Neoplasms | 2007 |
23 other study(ies) available for paclitaxel and Tongue Neoplasms
| Article | Year |
|---|---|
The Apoptotic Activity of Curcumin Against Oral Cancer Cells Without Affecting Normal Cells in Comparison to Paclitaxel Activity.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Curcumin; Humans; Mouth Neoplasms; Paclitaxel; Reactive Oxygen Species; Tongue Neoplasms | 2023 |
Rare case of acquired perforating dermatosis induced by cetuximab.
Topics: Antineoplastic Agents; Cetuximab; Chemoradiotherapy, Adjuvant; Drug Eruptions; Female; Humans; Middle Aged; Paclitaxel; Tongue Neoplasms; Withholding Treatment | 2020 |
Panitumumab as an effective maintenance treatment in metastatic squamous cell carcinoma of the head and neck.
Topics: Anaphylaxis; Antineoplastic Agents; Antineoplastic Agents, Immunological; Carboplatin; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Maintenance Chemotherapy; Male; Middle Aged; Neoplasms, Second Primary; Paclitaxel; Palliative Care; Panitumumab; Progression-Free Survival; Randomized Controlled Trials as Topic; Research Design; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms | 2021 |
Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait.
Topics: Adult; Antineoplastic Agents, Immunological; Colitis, Ulcerative; Hashimoto Disease; Humans; Immune Checkpoint Inhibitors; Male; Nivolumab; Paclitaxel; Programmed Cell Death 1 Receptor; Remission Induction; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tongue Neoplasms; Treatment Failure | 2021 |
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Janus Kinases; Models, Biological; Neoplasm Invasiveness; Paclitaxel; Phenanthrenes; Signal Transduction; STAT3 Transcription Factor; Tongue Neoplasms | 2017 |
Radiotherapy alone or combined with chemotherapy for the treatment of squamous cell carcinoma of the base of the tongue.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Neck Dissection; Paclitaxel; Retrospective Studies; Tongue Neoplasms; Treatment Outcome | 2014 |
[The Combination Therapy of Gemcitabine Plus Paclitaxel Induced Complete Response in a Tongue Skin Brain Metastasis of Bladder Carcinoma: A Case Report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cystectomy; Deoxycytidine; Female; Gemcitabine; Humans; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Skin Neoplasms; Tongue Neoplasms; Urinary Bladder Neoplasms | 2015 |
Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma.
Topics: Animals; Antineoplastic Agents; ARNTL Transcription Factors; Blotting, Western; Carcinogenesis; Carcinoma, Squamous Cell; Chromatin Immunoprecipitation; Circadian Clocks; Drug Resistance, Neoplasm; Gene Knockdown Techniques; Genes, Tumor Suppressor; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Polymerase Chain Reaction; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Inhibition of mTOR/eIF4E by anti-viral drug ribavirin effectively enhances the effects of paclitaxel in oral tongue squamous cell carcinoma.
Topics: Animals; Antimetabolites; Antiviral Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; Neoplasm Transplantation; Nucleocytoplasmic Transport Proteins; Paclitaxel; Ribavirin; Signal Transduction; Tongue Neoplasms; TOR Serine-Threonine Kinases | 2017 |
IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Exotoxins; Humans; Interleukin-13; Mice; Mouth Neoplasms; Paclitaxel; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tongue Neoplasms; Transplantation, Heterologous | 2009 |
Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Brachytherapy; Carboplatin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Retrospective Studies; Tongue Neoplasms; Treatment Outcome | 2009 |
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongue.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Female; Fluorouracil; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Irinotecan; Leucovorin; Male; Middle Aged; Neck Dissection; Paclitaxel; Radiotherapy Dosage; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recombinant Proteins; Tongue Neoplasms | 2010 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
Hyaluronic acid-paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Disease Models, Animal; Humans; Hyaluronan Receptors; Hyaluronic Acid; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Paclitaxel; Tongue Neoplasms; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured | 2011 |
[Support of hematological homeostasis during chemotherapy with taxanes].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Docetaxel; Female; Fever; Follow-Up Studies; Homeostasis; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Protective Agents; Severity of Illness Index; Stomach Neoplasms; Taxoids; Tongue Neoplasms | 2011 |
[Inhibitory effect of tumor necrosis factor and interferon with chemotherapeutic drugs on the growth of cancer cell of tongue].
Topics: Antineoplastic Agents; Cell Division; Cisplatin; Drug Synergism; Fluorouracil; Humans; Interferon-gamma; Paclitaxel; Recombinant Proteins; Tongue Neoplasms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2000 |
A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Drug Delivery Systems; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Paclitaxel; Particle Size; Serum Albumin; Tongue Neoplasms | 2003 |
Epidermal growth factor receptor blockade potentiates apoptosis mediated by Paclitaxel and leads to prolonged survival in a murine model of oral cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; ErbB Receptors; Head and Neck Neoplasms; Humans; In Situ Nick-End Labeling; Ligands; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Mouth Neoplasms; Neoplasms; Paclitaxel; Phosphorylation; Propidium; Pyrimidines; Pyrroles; Tongue; Tongue Neoplasms; Tyrosine | 2003 |
Severe dermatologic reactions at multiple sites after paclitaxel administration.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Humans; Male; Middle Aged; Paclitaxel; Skin Ulcer; Tongue Neoplasms | 2004 |
Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Brachytherapy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Glossectomy; Humans; Intraoperative Care; Male; Middle Aged; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Patient Compliance; Radiotherapy Dosage; Radiotherapy, Adjuvant; Recovery of Function; Tongue Neoplasms; Treatment Outcome | 2004 |
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Glossectomy; Humans; Male; Neck Dissection; Neoadjuvant Therapy; Paclitaxel; Radiotherapy, Adjuvant; Retrospective Studies; Tongue Neoplasms | 2005 |
Concurrent platinum-based chemotherapy and simultaneous modulated accelerated radiation therapy for locally advanced squamous cell carcinoma of the tongue base.
Topics: Adult; Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Gastrostomy; Humans; Male; Middle Aged; Neck Dissection; Paclitaxel; Radiotherapy Dosage; Tongue Neoplasms | 2008 |
Luteolin induces apoptosis in oral squamous cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinases; Cyclins; Humans; Luteolin; Mice; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Poly(ADP-ribose) Polymerases; Tongue Neoplasms; Transplantation, Heterologous | 2008 |